BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/13/2025 1:39:48 PM | Browse: 21 | Download: 141
 |
Received |
|
2025-03-28 04:00 |
|
Peer-Review Started |
|
2025-03-28 04:00 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-04-03 08:56 |
|
Revised |
|
2025-04-10 16:04 |
|
Second Decision |
|
2025-05-12 02:38 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-05-12 09:14 |
|
Articles in Press |
|
2025-05-12 09:14 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2025-05-19 19:49 |
|
Typeset the Manuscript |
|
2025-05-30 04:06 |
|
Publish the Manuscript Online |
|
2025-06-13 13:39 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Progress in the study of therapeutic strategies for hepatoblastoma in children
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ran Tang, Shi-Qin Qi, Tao Zhang, Zhu-Bin Pan and Jia-Hua Xu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jia-Hua Xu, Professor, Department of Gastroenterology, Anhui Provincial Children’s Hospital, Wangjiang Street, Hefei 231000, Anhui Province, China. xujiahua.cn@163.com |
| Key Words |
Hepatoblastoma; Children; Liver cancer; Surgical resection; Chemotherapy; Targeted therapy |
| Core Tip |
Hepatoblastoma (HB) is the most common malignant liver tumor in children, and its treatment has evolved remarkably in recent years. This review comprehensively summarizes the latest advances in HB epidemiology, molecular classification, risk stratification, surgical innovations, and systemic therapies. Emphasis is placed on current challenges and critical comparisons of treatment modalities, such as surgical timing, neoadjuvant chemotherapy, liver transplantation, and targeted therapies. By integrating updated evidence and proposing future research directions, this article provides practical insights to guide clinical decision-making and promote individualized, precision therapy in pediatric HB. |
| Publish Date |
2025-06-13 13:39 |
| Citation |
<p>Tang R, Qi SQ, Zhang T, Pan ZB, Xu JH. Progress in the study of therapeutic strategies for hepatoblastoma in children. <i>World J Gastrointest Oncol</i> 2025; 17(6): 107700</p> |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i6/107700.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i6.107700 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
